サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：早産およびPROM検査の世界市場 (2022～2030年)：成長・将来の展望・競合分析
市場調査レポート
商品コード
1162482

早産およびPROM検査の世界市場 (2022～2030年)：成長・将来の展望・競合分析

Preterm Birth And PROM Testing Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
早産およびPROM検査の世界市場 (2022～2030年)：成長・将来の展望・競合分析
出版日: 2022年08月23日
発行: Acute Market Reports
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

早産およびPROM検査の市場規模は、2022年から2030年にかけての予測期間中の2.1％のCAGRで成長するとされています。

優れた診断精度と感度により、PROM検査キットとしてのバイオマーカーの普及が期待されています。アルファフェトプロテイン検査 (AFT) 、インスリン様成長因子結合タンパク質-1 (IGFBP-1) 、胎盤アルファマクログロブリン-1 (PAMG-1) などのバイオマーカーがこの10年間で非常に注目されています。優れた診断精度と感度が、PROM検査キットとしてのバイオマーカーの人気を高めています。

当レポートでは、世界の早産およびPROM検査の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 早産およびPROM検査市場：事業の見通し・市場力学

  • 世界市場の規模：2020年～2030年
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 早産およびPROM検査市場：検査別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • 内診
    • シダ状結晶形成検査
    • ニトラジン試験
    • プーリング検査
    • 超音波検査
    • 子宮モニタリング検査
    • バイオマーカー

第5章 北米の早産およびPROM検査市場

  • 市場概要
  • 早産およびPROM検査市場：検査別
  • 早産およびPROM検査市場：地域別

第6章 英国およびEUの早産およびPROM検査市場

  • 市場概要
  • 早産およびPROM検査市場：検査別
  • 早産およびPROM検査市場：地域別

第7章 アジア太平洋の早産およびPROM検査市場

  • 市場概要
  • 早産およびPROM検査市場：検査別
  • 早産およびPROM検査市場：地域別

第8章 ラテンアメリカの早産およびPROM検査市場

  • 市場概要
  • 早産およびPROM検査市場：検査別
  • 早産およびPROM検査市場：地域別

第9章 中東・アフリカの早産およびPROM検査市場

  • 市場概要
  • 早産およびPROM検査市場：検査別
  • 早産およびPROM検査市場：地域別

第10章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical, Inc.
  • Hologic, Inc.
  • IQ Products.
  • Medixbiochemica
  • NX Prenatal, Inc.
  • Qiagen N.V.
  • Sera Prognostics, Inc.
図表

List of Tables

  • TABLE 1 Global Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 2 North America Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 3 UK and European Union Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 4 Asia Pacific Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 5 Latin America Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)
  • TABLE 6 Middle East and Africa Preterm Birth And PROM Testing Market By Test, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Preterm Birth And PROM Testing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Preterm Birth And PROM Testing Market: Quality Assurance
  • FIG. 5 Global Preterm Birth And PROM Testing Market, By Test, 2021
  • FIG. 6 Global Preterm Birth And PROM Testing Market, By Geography, 2021
  • FIG. 7 Global Preterm Birth And PROM Testing Market, By Test, 2021 Vs 2030, %
  • FIG. 8 U.S. Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 15 France Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 17 China Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 19 India Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Preterm Birth And PROM Testing Market (US$ Million), 2020 - 2030
目次
Product Code: 138654-08-22

Industry Outlook

The preterm birth and PROM testing market is set to growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2022 to 2030. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are: Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Preterm Birth And PROM Testing market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Preterm Birth And PROM Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

  • Pelvic Exam
  • Ferning Test
  • Nitrazine Test
  • Pooling Test
  • Ultrasound Test
  • Uterine Monitoring Test
  • Biomarkers

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Preterm Birth And PROM Testing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Preterm Birth And PROM Testing market?
  • Which is the largest regional market for Preterm Birth And PROM Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Preterm Birth And PROM Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Preterm Birth And PROM Testing market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Preterm Birth And PROM Testing Market
  • 2.2. Global Preterm Birth And PROM Testing Market, By Test, 2021 (US$ Million)
  • 2.3. Global Preterm Birth And PROM Testing Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Preterm Birth And PROM Testing Market Vendors
    • 2.6.2. Strategies Adopted by Preterm Birth And PROM Testing Market Vendors
    • 2.6.3. Key Industry Strategies

3. Preterm Birth And PROM Testing Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Preterm Birth And PROM Testing Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Pelvic Exam
    • 4.3.2. Ferning Test
    • 4.3.3. Nitrazine Test
    • 4.3.4. Pooling Test
    • 4.3.5. Ultrasound Test
    • 4.3.6. Uterine Monitoring Test
    • 4.3.7. Biomarkers

5. North America Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 5.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 6.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 7.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 8.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Preterm Birth And PROM Testing Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Preterm Birth And PROM Testing Market: By Test, 2020-2030, USD (Million)
  • 9.3.Preterm Birth And PROM Testing Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. Abbott Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Biosynex
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Clinical Innovations, LLC
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. CooperSurgical, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Hologic, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. IQ Products.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Medixbiochemica
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. NX Prenatal, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Qiagen N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Sera Prognostics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives